Search
for
Sort by
Research 151–180 of 1000+
- New onset of alopecia in a young woman with end-stage renal disease
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Epigenetic orchestration of RNA m<sup>6</sup>A methylation in wound healing and post-wound events
- Farmácia São Lázaro - Porto e nos Serviços Farmacêuticos do Hospital Privado de Vila Real (Grupo Trofa Saúde) - Vila Real
- Minoxidil oral en alopecia androgénica: estudio retrospectivo acerca de su seguridad en práctica clínica real
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- Suicidality and Psychological Adverse Events in Patients Treated with Finasteride
- Real-world evidence in alopecia areata treatment: A narrative review
- Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia
- Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab
- Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Gender-Affirming Hormone Therapy for Transgender Females
- Hormonal therapies for acne
- Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
- Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients
- The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
- Treatments for alopecia areata: a network meta-analysis
- Diuretics
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Poster Abstracts
- Alopecias